Literature DB >> 6174734

Preferential binding of chlordecone to the protein and high density lipoprotein fractions of plasma from humans and other species.

P J Soine, R V Blanke, P S Guzelian, C C Schwartz.   

Abstract

The preferential distribution of the relatively nonpolar pesticide chlordecone (CD) to liver rather than to fat tissues in humans suggests that it may be transported in plasma differently from other organochlorine pesticides. The plasma binding of [14C] CD was investigated in vitro in human, rat, and pig plasma and in vivo in rat plasma. Protein and lipoprotein fractions were separated by serial ultracentrifugation. Heparin-manganese precipitation and agarose gel electrophoresis were also carried out to determine whether separation techniques altered CD binding to plasma components. In human plasma, the distribution of [14C] CD among proteins and high density, low density, and very low density lipoproteins (HDL, LDL, and VLDL) was 46, 30, 20, and 6%, respectively. The distribution of cholesterol in the same plasma fractions was 4, 20, 63, and 7%, respectively. In the pig and rat the order of binding was similar to that in humans, with protein greater than or equal to HDL greater than LDL greater than or equal to VLDL. Separation by heparin-Mn precipitation confirmed the results obtained by ultracentrifugation. The distribution of [14C] CD in rat lipoprotein was similar whether the CD was administered in vivo or incubated with plasma in vitro, with approximately 80% bound to HDL, 11% to LDL, and 9% to VLDL in either case. Agarose gel electrophoresis of plasma-bound [14C] CD indicated that albumin was the major component of the protein fraction responsible for CD binding. Preferential binding of CD by albumin and HDL may explain its unusual tissue distribution compared to other organochlorine pesticides such as aldrin and dieldrin, which bind preferentially to VLDL and LDL and distribute preferentially to fat tissues.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174734     DOI: 10.1080/15287398209530146

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  9 in total

Review 1.  Adipose Tissue as a Site of Toxin Accumulation.

Authors:  Erin Jackson; Robin Shoemaker; Nika Larian; Lisa Cassis
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

2.  Distribution of toxaphene, DDT, and PCB among lipoprotein fractions in rat and human plasma.

Authors:  A Mohammed; A Eklund; A M Ostlund-Lindqvist; P Slanina
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  A PBPK model describing the pharmacokinetics of γ-HBCD exposure in mice.

Authors:  Claude Emond; Michael J DeVito; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2021-08-11       Impact factor: 4.460

4.  Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-02-06       Impact factor: 4.219

5.  Transport of organochlorine residues in the rat and human blood.

Authors:  J Gómez-Catalán; J To-Figueras; M Rodamilans; J Corbella
Journal:  Arch Environ Contam Toxicol       Date:  1991-01       Impact factor: 2.804

6.  Chlordecone exposure and adverse effects in French West Indies populations.

Authors:  Luc Multigner; Philippe Kadhel; Florence Rouget; Pascal Blanchet; Sylvaine Cordier
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-05       Impact factor: 4.223

7.  Chlordecone: development of a physiologically based pharmacokinetic tool to support human health risks assessments.

Authors:  Claude Emond; Luc Multigner
Journal:  Arch Toxicol       Date:  2022-02-05       Impact factor: 5.153

8.  Activated carbon, a useful medium to bind chlordecone in soil and limit its transfer to growing goat kids.

Authors:  Sarah Yehya; Matthieu Delannoy; Agnès Fournier; Moomen Baroudi; Guido Rychen; Cyril Feidt
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

9.  Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.

Authors:  Petr Kocis; Martin Tolar; Jeremy Yu; William Sinko; Soumya Ray; Kaj Blennow; Howard Fillit; John A Hey
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.